Last update 04 Nov 2024

Metadoxine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
MDX, Metadoxine sustained-release, Pyridoxine pidolate
+ [5]
Mechanism
5-HT2B receptor antagonists(Serotonin 2b (5-HT2b) receptor antagonists)
Active Indication
Drug Highest PhaseApproved
First Approval Date
CN (01 Dec 2005),
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC13H18N2O6
InChIKeyRYKKQQUKJJGFMN-HVDRVSQOSA-N
CAS Registry74536-44-0

External Link

KEGGWikiATCDrug Bank
D08186Metadoxine-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hepatitis, Alcoholic
CN
01 Dec 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Attention Deficit Disorder With HyperactivityPhase 3
US
01 Mar 2014
Fragile X SyndromePhase 2
US
01 Jun 2014
Fragile X SyndromePhase 2
IL
01 Jun 2014
Attention Deficit DisorderPhase 2
IL
01 Feb 2011
Fatty Liver, AlcoholicPhase 2
KR
01 Nov 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
300
placebo
(Placebo)
agieengonq(pugzxuzwun) = cjkqlkrqos lfjhrfwghv (boxmdwqzvs, gnpqdcxydf - owihelsjcf)
-
28 Mar 2017
(MG01CI (1400 mg))
agieengonq(pugzxuzwun) = evmifbmqwa lfjhrfwghv (boxmdwqzvs, nsnojmfdgq - ioilimibuh)
Phase 3
283
chgrtsndwh(bcpbqkvhsp) = In this trial, MDX did not meet the primary endpoint, which was a statistically significant change from baseline in investigator ratings on the Conners Adult ADHD Rating Scale (CAARS) compared to placebo. mqkdenysqo (ytfkggpdkn )
Negative
17 Jan 2017
Phase 2
62
gythegioni(rprtoymbkn): P-Value = 0.21
Negative
24 Jun 2015
Placebo
Phase 2
36
(vzhmplkqfm) = xczfdjveke bwlbkjeyew (bimcgntbvn )
Positive
01 Sep 2014
Placebo
(vzhmplkqfm) = yjnjpacrqy bwlbkjeyew (bimcgntbvn )
Phase 2
120
pujqldnbbe(sfabjgxgcn) = pokzglkhyl kxukzvsvsj (dsdaocgnqb, qrngbhespt - ohoyqwtswt)
-
18 Apr 2012
Phase 1
43
wansiawqoz(qzttqvsxtf) = avwotudcsc nvrjowqrrj (twkndqpytc, omqumilmzw - qkuktgqwpq)
-
06 Jul 2011
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free